Neurologic Manifestations of Systemic Lupus Erythematosus in Children and Adults

Neurologic Clinics

Volumn 28, Issue 1, 2010, Pages 61-73

  Muscal, Eyal ^a   Brey, Robin L ^b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Autoantibodies; Cognitive dysfunction; Collagen vascular disease; Neurologic disease; Systemic lupus erythematosus

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; AUTOANTIBODY; COLLAGEN; CORTICOSTEROID; CREATINE; CYCLOPHOSPHAMIDE; CYTOKINE; GLUTAMATE RECEPTOR; HYDROXYCHLOROQUINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; N ACETYLASPARTIC ACID; PHOSPHOLIPID ANTIBODY; RITUXIMAB;

ANTIBODY PRODUCTION; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BRAIN ATROPHY; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; CRANIAL NEUROPATHY; CYTOKINE PRODUCTION; HEADACHE; HUMAN; INFLAMMATION; LABORATORY TEST; MENTAL DISEASE; MICROANGIOPATHY; MOOD DISORDER; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SEIZURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANIMALS; BRAIN; CHILD; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; PREVALENCE;

EID: 70449650511     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2009.09.004     Document Type: Review

References (64)

1. Danchenko N., Satia J.A., and Anthony M.S. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 15 (2006) 308-318
2. Brey R.L., Holliday S.L., Saklad A.R., et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 58 (2002) 1214-1220
3. McLaurin E.Y., Holliday S.L., Williams P., et al. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology 64 (2005) 297-303
4. Harel L., Sandborg C., Lee T., et al. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies. J Rheumatol 33 (2006) 1873-1877
5. Hanly J.G., Urowitz M.B., Sanchez-Guerrero J., et al. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum 56 (2007) 265-273
6. Sibbitt Jr. W.L., Brandt J.R., Johnson C.R., et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 29 (2002) 1536-1542
7. Yu H.H., Lee J.H., Wang L.C., et al. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study. Lupus 15 (2006) 651-657
8. Bernatsky S., Clarke A., Gladman D.D., et al. Mortality related to cerebrovascular disease in systemic lupus erythematosus. Lupus 15 (2006) 835-839
9. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42 (1999) 599-608
10. Ainiala H., Loukkola J., Peltola J., et al. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 57 (2001) 496-500
11. Mikdashi J., and Handwerger B. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Rheumatology 43 (2004) 1555-1560
12. Zhu T.Y., Tam A.S., Lee V.W.Y., et al. Systemic lupus erythematosis with neuropsychiatric manifestations incurs high disease costs: a cost-of-illness study in Hong Kong. Rheumatology 48 (2009) 564-568
13. Benseler S.M., and Silverman E.D. Neuropsychiatric involvement in pediatric systemic lupus erythematosus. Lupus 16 (2007) 564-571
14. Hiraki L.T., Benseler S.M., Tyrrell P.N., et al. Clinical and laboratory characteristics and long-term outcomes of pediatric systemic lupus erythematosus: a longitudinal study. J Pediatr 152 (2008) 550-556
15. Petri M., Naqibuddin M., Carson K.A., et al. Cognitive function in a systemic lupus erythematosus inception cohort. J Rheumatol 35 9 (2008) 1776-1781
16. Costallat L., Bertolo M., and Appenzeller S. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes: analysis of 527 patients. Lupus 10 (2001) S32
17. Hanly J.G., Urowitz M.B., Sanchez-Guerrero J., et al. Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study. Arthritis Rheum 59 (2008) 721-729
18. Carreno L., Lopez-Longo F.J., Monteagudo I., et al. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus. Lupus 8 4 (1999) 287-292
19. Brunner H.I., Silverman E.D., To T., et al. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 46 2 (2002) 436-444
20. Brunner H.I., Gladman D.D., Ibanez D., et al. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 58 2 (2008) 556-562
21. Tucker L.B., Uribe A.G., Fernandez M., et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 17 4 (2008) 314-322
22. Hoffman I.E.A., Lauwerys B.R., DeKeyser F., et al. Juvenile-onset systemic lupus erythemotosis: different clinical and serological pattern than adult-onset systemic lupus erythematosus. Ann Rheum Dis 68 (2009) 412-415
23. Papero P.H., Bluestein H.G., White P., et al. Neuropsychologic deficits and antineuronal antibodies in pediatric systemic lupus erythematosus. Clin Exp Rheumatol 8 4 (1990) 417-424
24. Brunner H.I., Ruth N.M., German A., et al. Initial validation of the Pediatric Automated Neuropsychological Assessment Metrics for childhood-onset systemic lupus erythematosus. Arthritis Rheum 57 7 (2007) 1174-1182
25. Hanly J.G. Neuropsychiatric lupus. Curr Rheumatol Rep 3 (2001) 205-212
26. Sakic B., Kolb B., Whishaw I.Q., et al. Immunosuppression prevents neuronal atrophy in lupus-prone mice: evidence for brain damage induced by autoimmune disease?. J Neuroimmunol 111 1-2 (2000) 93-101
27. Sakic B., Kirkham D.L., Ballok D.A., et al. Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease. J Neuroimmunol 169 1-2 (2005) 68-85
28. Hanly J.G., Walsh N.M., and Sangalang V. Brain pathology in systemic lupus erythematosus. J Rheumatol 19 (1992) 732-741
29. Belmont H.M., Abramson S.B., and Lie J.T. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium. Arthritis Rheum 39 (1996) 9-22
30. Abbott N.J., Mendonca L.L., and Dolman D.E. The blood-brain barrier in systemic lupus erythematosus. Lupus 12 (2003) 908-915
31. Zaccagni H., Fried J., Cornell J., et al. Soluble adhesion molecule levels, neuropsychiatric lupus and lupus-related damage. Front Biosci 9 (2004) 1654-1659
32. Spronk P.E., Bootsma H., Huitema M.G., et al. Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study. Clin Exp Immunol 97 (1994) 439-444
33. Ainiala H., Hietaharju A., Dastidar P., et al. Increased serum metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities. Arthritis Rheum 50 (2004) 858-865
34. Nishimura K., Harigai M., Omori M., et al. Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus. Psychoneuroendocrinology 33 (2008) 395-403
35. Cervera R., Khamashta M.A., Font J., et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine 82 (2003) 299-308
36. Hanly J.G., Hong C., Smith S., et al. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 42 4 (1999) 728-734
37. Menon S., Jameson-Shortall E., Newman Hall-Craggs S.P., et al. A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus. Arthritis Rheum 42 4 (1999) 735-741
38. DeGiorgio L.A., Konstantinov K.N., Lee S.C., et al. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus [comment]. Nat Med 7 (2001) 1189-1193
39. Husebye E.S., Sthoeger Z.M., Dayan M., et al. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus. Ann Rheum Dis 64 (2005) 1210-1213
40. Omdal R., Brokstad K., Waterloo K., et al. Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors. Eur J Neurol 12 (2005) 392-398
41. Harrison M., Ravdin L., Volpe B., et al. Anti-NR2 antibody does not identify cognitive impairment in a general SLE population. Arthritis Rheum 50 (2004) S596
42. Lapteva L., Nowak M., Yarboro C.H., et al. Anti-N-methyl-d-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum 54 (2006) 2505-2514
43. Kowal C., Degiorgio L.A., Lee J.Y., et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A 103 (2006) 19854-19859
44. Klingberg T., Vaidya C.J., Gabrieli J.D., et al. Myelination and organization of the frontal white matter in children: a diffusion tensor MRI study. Neuroreport 10 13 (1999) 2817-2821
45. Nagy Z., Westerberg H., and Klingberg T. Maturation of white matter is associated with the development of cognitive functions during childhood. J Cogn Neurosci 16 7 (2004) 1227-1233
46. Filley C.M. The behavioral neurology of cerebral white matter. Neurology 50 6 (1998) 1535-1540
47. Futrell N., Schultz L.R., and Millikan C. Central nervous system disease in patients with systemic lupus erythematosus. Neurology 42 (1992) 1649-1657
48. Appenzeller S., Rondina J.M., Li L.M., et al. Cerebral and corpus callosum atrophy in systemic lupus erythematosus. Arthritis Rheum 52 9 (2005) 2783-2789
49. Sibbitt Jr. W.L., Sibbitt R.R., and Brooks W.M. Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 42 (1999) 2026-2038
50. Abreu M.R., Jakosky A., Folgerini M., et al. Neuropsychiatric systemic lupus erythematosus: correlation of brain MR imaging, CT, and SPECT. Clin Imaging 29 (2005) 215-221
51. Appenzeller S., Carnevalle A.D., Li L.M., et al. Hippocampal atrophy in systemic lupus erythematosus. Ann Rheum Dis 65 (2006) 1585-1589
52. Petri M., Naqibuddin M., Carson K.A., et al. Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus. J Rheumatol 35 12 (2008) 2348-2354
53. Kozora E., Arciniegas D.B., Filley C.M., et al. Cognition, MRS neurometabolites, and MRI volumetrics in non-neuropsychiatric systemic lupus erythematosus: preliminary data. Cogn Behav Neurol 18 3 (2005) 159-162
54. Chinn R.J., Wilkinson I.D., Hall-Craggs M.A., et al. Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. Arthritis Rheum 40 (1997) 36-46
55. Zhang L., Harrison M., Heier L.A., et al. Diffusion changes in patients with systemic lupus erythematosus. Magn Reson Imaging 25 3 (2007) 399-405
56. Hughes M., Sundgren P.C., Fan X., et al. Diffusion tensor imaging in patients with acute onset of neuropsychiatric systemic lupus erythematosus: a prospective study of apparent diffusion coefficient, fractional anisotropy values, and eigenvalues in different regions of the brain. Acta Radiol 48 2 (2007) 213-222
57. Bosma G.P., Steens S.C., Petropoulos H., et al. Multisequence magnetic resonance imaging study of neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 50 10 (2004) 3195-3202
58. Falcini F., De Cristofaro M.T., Ermini M., et al. Regional cerebral blood flow in juvenile systemic lupus erythematosus: a prospective SPECT study. Single photon emission computed tomography. J Rheumatol 25 3 (1998) 583-588
59. Mortilla M., Ermini M., Nistri M., et al. Brain study using magnetic resonance imaging and proton MR spectroscopy in pediatric onset systemic lupus erythematosus. Clin Exp Rheumatol 21 1 (2003) 129-135
60. O'Neill S.G., and Schrieber L. Immunotherapy of systemic lupus erythematosus. Autoimmun Rev 4 (2005) 395-402
61. Haupt M., Millen S., Janner M., et al. Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis 64 (2005) 1618-1623
62. Petri M., and Brodsky R. High-dose cyclophosphamide and stem cell transplantation for refractory systemic lupus erythematosus. JAMA 295 (2006) 559-560
63. Barile-Fabris L., Ariza-Andraca R., Olguin-Ortega L., et al. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis 64 4 (2005) 620-625
64. Burt R.K., Traynor A., Statkute L., et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 295 (2006) 527-535